221 related articles for article (PubMed ID: 33755092)
21. Chronic Myelomonocytic Leukemia: Focus on Clinical Practice.
Patnaik MM; Tefferi A
Mayo Clin Proc; 2016 Feb; 91(2):259-72. PubMed ID: 26848006
[TBL] [Abstract][Full Text] [Related]
22. Recent advances in diagnosis, molecular pathology and therapy of chronic myelomonocytic leukaemia.
Bacher U; Haferlach T; Schnittger S; Kreipe H; Kröger N
Br J Haematol; 2011 Apr; 153(2):149-67. PubMed ID: 21401573
[TBL] [Abstract][Full Text] [Related]
23. Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management.
Patnaik MM; Tefferi A
Am J Hematol; 2016 Jun; 91(6):631-42. PubMed ID: 27185207
[TBL] [Abstract][Full Text] [Related]
24. How I diagnose and treat chronic myelomonocytic leukemia.
Patnaik MM
Haematologica; 2022 Jul; 107(7):1503-1517. PubMed ID: 35236051
[TBL] [Abstract][Full Text] [Related]
25. Significance of WT1 and multiparameter flow cytometry assessment in patients with chronic myelomonocytic leukemia receiving allogeneic hematopoietic stem cell transplantation.
Pan X; Gao M; Sun Y; Zhou Y; Wang K; Wang Y; Xu L; Zhang X; Huang X; Zhao XS
Int J Lab Hematol; 2022 Jun; 44(3):510-517. PubMed ID: 35061336
[TBL] [Abstract][Full Text] [Related]
26. Allogeneic stem cell transplantation for chronic myelomonocytic leukemia: a report from the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire.
Park S; Labopin M; Yakoub-Agha I; Delaunay J; Dhedin N; Deconinck E; Michallet M; Robin M; De Revel T; Bernard M; Vey N; Lioure B; Lapusan S; Tabrizi R; Bourhis JH; Huynh A; Beguin Y; Socié G; Dreyfus F; Fenaux P; Mohty M
Eur J Haematol; 2013 May; 90(5):355-64. PubMed ID: 23320648
[TBL] [Abstract][Full Text] [Related]
27. Chronic myelomonocytic leukemia: 2012 update on diagnosis, risk stratification, and management.
Parikh SA; Tefferi A
Am J Hematol; 2012 Jun; 87(6):610-9. PubMed ID: 22615103
[TBL] [Abstract][Full Text] [Related]
28. [Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].
Harada Y; Harada H
Rinsho Ketsueki; 2016 Feb; 57(2):147-55. PubMed ID: 26935632
[TBL] [Abstract][Full Text] [Related]
29. Chronic Myelomonocytic Leukemia: a Genetic and Clinical Update.
McCullough KB; Patnaik MM
Curr Hematol Malig Rep; 2015 Sep; 10(3):292-302. PubMed ID: 26122388
[TBL] [Abstract][Full Text] [Related]
30. Chronic Myelomonocytic Leukemia: Insights into Biology, Prognostic Factors, and Treatment.
Coltro G; Patnaik MM
Curr Oncol Rep; 2019 Nov; 21(11):101. PubMed ID: 31728739
[TBL] [Abstract][Full Text] [Related]
31. Isolated CNS relapse in FLT 3 mutation positive CMML post allogeneic stem cell transplant: Report of a rare case.
Mutreja D; Verma S; Venkatesan S; Sharma S; Das S
Indian J Pathol Microbiol; 2021; 64(1):189-191. PubMed ID: 33433440
[TBL] [Abstract][Full Text] [Related]
32. Role of allogeneic transplantation in chronic myelomonocytic leukemia: an international collaborative analysis.
Robin M; de Wreede LC; Padron E; Bakunina K; Fenaux P; Koster L; Nazha A; Beelen DW; Rampal RK; Sockel K; Komrokji RS; Gagelmann N; Eikema DJ; Radujkovic A; Finke J; Potter V; Killick SB; Legrand F; Solary E; Broom A; Garcia-Manero G; Rizzoli V; Hayden P; Patnaik MM; Onida F; Yakoub-Agha I; Itzykson R
Blood; 2022 Sep; 140(12):1408-1418. PubMed ID: 35667047
[TBL] [Abstract][Full Text] [Related]
33. Moving towards a uniform risk stratification system in CMML - How far are we?
Chan O; Padron E
Best Pract Res Clin Haematol; 2020 Jun; 33(2):101131. PubMed ID: 32460982
[TBL] [Abstract][Full Text] [Related]
34. Chronic myelomonocytic leukemia - a review.
Thomopoulos TP; Bouhla A; Papageorgiou SG; Pappa V
Expert Rev Hematol; 2021 Jan; 14(1):59-77. PubMed ID: 33275852
[TBL] [Abstract][Full Text] [Related]
35. Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and management.
Patnaik MM; Tefferi A
Am J Hematol; 2022 Mar; 97(3):352-372. PubMed ID: 34985762
[TBL] [Abstract][Full Text] [Related]
36. Prognostic scoring systems and comorbidities in chronic myelomonocytic leukaemia: a nationwide population-based study.
Moreno Berggren D; Kjellander M; Backlund E; Engvall M; Garelius H; Lorenz F; Nilsson L; Rasmussen B; Lehmann S; Hellström-Lindberg E; Jädersten M; Ungerstedt J; Ejerblad E
Br J Haematol; 2021 Feb; 192(3):474-483. PubMed ID: 32501529
[TBL] [Abstract][Full Text] [Related]
37. [Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].
Qu SQ; Pan LJ; Qin TJ; Xu ZF; Li B; Wang HJ; Sun Q; Jia YJ; Li CW; Cai WY; Gao QY; Jiao M; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):373-379. PubMed ID: 37550186
[No Abstract] [Full Text] [Related]
38. Contemporary Risk Stratification and Treatment of Chronic Myelomonocytic Leukemia.
Tremblay D; Rippel N; Feld J; El Jamal SM; Mascarenhas J
Oncologist; 2021 May; 26(5):406-421. PubMed ID: 33792103
[TBL] [Abstract][Full Text] [Related]
39. Age-related mutations and chronic myelomonocytic leukemia.
Mason CC; Khorashad JS; Tantravahi SK; Kelley TW; Zabriskie MS; Yan D; Pomicter AD; Reynolds KR; Eiring AM; Kronenberg Z; Sherman RL; Tyner JW; Dalley BK; Dao KH; Yandell M; Druker BJ; Gotlib J; O'Hare T; Deininger MW
Leukemia; 2016 Apr; 30(4):906-13. PubMed ID: 26648538
[TBL] [Abstract][Full Text] [Related]
40. Blast transformation in chronic myelomonocytic leukemia: Risk factors, genetic features, survival, and treatment outcome.
Patnaik MM; Wassie EA; Lasho TL; Hanson CA; Ketterling R; Tefferi A
Am J Hematol; 2015 May; 90(5):411-6. PubMed ID: 25645147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
